This registration is for the Zoom participation option of this HyFlex course.

The DNA revolution and biotechnology have again afforded dramatic advances over the past year, most notable the first approval of human genome editing for therapeutic benefit. But can we spot the developments that promise lasting benefit, and those that may do more harm than good? In this course we will look at a wide array of research from A (Alzheimer’s disease) to Y (the ‘male’ chromosome) and much in between. We also cannot ignore the incursion of artificial intelligence into biotechnology R&D and healthcare.

We will have two guest speakers. The first will provide us with a perspective of the uses of AI in medicine; the second will share insights into the newly approved treatments for Alzheimer’s disease and their research findings that may point to a new understanding of the cause of Alzheimer’s disease. Participants will be invited to propose findings for discussion that they have encountered over the last year.

Course participants need no specialist knowledge. Whether you are a new student or participating again, everyone should enjoy this course if they are curious about our understanding of the human genome and the development of new technologies that are affecting our lives.